Total Funding
47
Total FundingNon-equity Assistance raised
Growth Score
pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
183574
PB&B is a life sciences startup developing a new generation of fillers and soft tissue remodeling injections for plastic surgeons.
Anthony Aho: CEO & Co-FounderPast Role: EPFL, Technology Transfert Office (TTO) intern
Sandeep Raghunathan: Chief of Science & StrategyPast Role: Merck Serono, Scientific collaborator
About the Company
PB&B SA is an early-stage Life Sciences company founded in 2013 by bioengineers who teamed up with plastic surgeons & scientists to create natural & minimally invasive solutions for facial aging & body remodeling. PB&B developed an injection to increase adipose (fat) volume in situ using the most advanced microencapsulation
& drug delivery technologies.
PB&B’s patented technology aims to transform a fast-growing, multi-billion-dollar body shaping market by targeting under-served needs with a simple, fast and safer alternative to fat transfer. Products have been designed for Plastic Surgeons and Aesthetic Injectors active in body shaping procedures for facial, hands, décolleté and buttock enhancement indications.
